The Superiority of Zoledronic Acid Over Risedronate for Paget’s Disease: A 16-Year Experience at a Single Institution

Introduction Bisphosphonates are considered to be the treatment of choice for patients with active Paget’s disease. The aim of this study was to record and assess the therapeutic effect in response to a single intravenous infusion of 5mg zoledronic acid or oral risedronate. Methods A retrospective o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zidrou, Christiana, Rizou, Stavroula, Beletsiotis, Anastasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Orthopedics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873448/
https://www.ncbi.nlm.nih.gov/pubmed/36712714
http://dx.doi.org/10.7759/cureus.32923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873448/
https://www.ncbi.nlm.nih.gov/pubmed/36712714
http://dx.doi.org/10.7759/cureus.32923

Ejemplares similares